Bone morphogenetic protein 2 stimulates chondrogenesis of equine synovial membrane-derived progenitor cells.

This research examines the effectiveness of Bone morphogenetic protein 2 (BMP-2) in triggering chondrogenesis (cartilage formation) in progenitor cells sourced from the synovial membrane in horses. The results support the use of BMP-2 and these cells for applications in articular cartilage repair.

Cloning and Characterizing BMP-2

• The study began with amplifying equine BMP-2 cDNA extracted from chondrocyte RNA. This amplified DNA was then transferred into a plasmid expression construct and an adenoviral vector to facilitate future gene expression studies.
• The successful introduction and expression of equine BMP-2 were confirmed using a BMP-specific reporter cell line.

Stimulating Chondrogenesis in SMPC

• Next, the researchers isolated synovial membrane-derived progenitor cells (SMPC) and expanded them through two passages, transferring them to cultures meant to induce chondrogenesis.
• They introduced recombinant human transforming growth factor beta 1 (TGF-β1) or recombinant human BMP-2 into these cultures.
• Analyses focused on an increase in the expression of collagen types II and X and aggrecan mRNA, as well as an increase in the production of collagen type II protein and sulfated glycosaminoglycans (sGAG).
• Chondrogenic stimulation of SMPC by the equine BMP-2 adenovirus was assessed via measurements of sGAG secretion and histological analyses.

Key Results

• The mature equine BMP-2 peptide shows identical characteristics to human and murine BMP-2 peptides.
• Both recombinant human BMP-2 and TGF-β1 led to similar levels of collagen type II protein in the SMPC cell populations, but BMP-2 doubled the amount of sGAG that was secreted.
• Even though both BMP-2 or TGF-beta 1 were effective chondrogenic factors, neither led to an increase in the expression of hypertrophic (abnormally increased growth) markers.
• The equine BMP-2 adenoviral vector was as effective as recombinant human BMP-2 protein in inducing chondrogenesis, again with no signs of hypertrophic activity.

Conclusion

• Based on their findings, the researchers conclude that BMP-2 is a potent instigator of non-hypertrophic chondrogenesis in SMPCs.
• This suggests that the combination of BMP-2 and SMPCs could potentially be used in applications for repairing cartilage in joints, offering a possible therapeutic strategy for conditions such as osteoarthritis.